对羟乙基淀粉溶液使用的担忧。
Concerns over use of hydroxyethyl starch solutions.
作者信息
Hartog Christiane S, Natanson Charles, Sun Junfeng, Klein Harvey G, Reinhart Konrad
机构信息
Department of Anaesthesiology and Intensive Care Medicine, Centre for Sepsis Care and Control, Jena University Hospital, D-07747 Jena, Germany.
Critical Care Medicine Department, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
BMJ. 2014 Nov 10;349:g5981. doi: 10.1136/bmj.g5981.
Abstract
Large trials have shown that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. However, an EMA review last year permitted continued use in some patients, overturning an earlier decision to withdraw the product completely. discuss the evidence and call on doctors to avoid using starch formulations
摘要
大型试验表明，羟乙基淀粉会增加死亡、肾损伤和出血风险。然而，欧洲药品管理局（EMA）去年的一项审查允许在某些患者中继续使用，推翻了此前完全撤市该产品的决定。讨论了相关证据，并呼吁医生避免使用淀粉制剂
相似文献
1
Concerns over use of hydroxyethyl starch solutions.
BMJ. 2014 Nov 10;349:g5981. doi: 10.1136/bmj.g5981.
2
Volume therapy with hydroxyethyl starches: are we throwing the anesthesia baby out with the intensive care unit bathwater?
Anesth Analg. 2014 Sep;119(3):737-739. doi: 10.1213/ANE.0000000000000221.
3
Hydroxyethyl starch: here today, gone tomorrow.
Br J Anaesth. 2013 Sep;111(3):321-4. doi: 10.1093/bja/aet294.
4
Hydroxyethyl starches: a tale of two contexts: the problem of knowledge.
Anesth Analg. 2014 Sep;119(3):509-513. doi: 10.1213/ANE.0000000000000323.
5
Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
Blood Transfus. 2016 May;14(2):195-6. doi: 10.2450/2016.0061-16. Epub 2016 Mar 5.
6
Tetrastarch solutions: are they definitely dead?
Br J Anaesth. 2013 Sep;111(3):324-7. doi: 10.1093/bja/aet300.
7
Bring rapidly degradable hydroxyethyl starch to the United States.
Anesthesiology. 2006 May;104(5):1105-6; author reply 1106. doi: 10.1097/00000542-200605000-00032.
8
Is the literature inconclusive about the harm from HES? No.
Intensive Care Med. 2017 Oct;43(10):1523-1525. doi: 10.1007/s00134-016-4275-x. Epub 2016 Mar 23.
9
NHS should ban use of starch based intravenous fluids, say researchers.
BMJ. 2013 Feb 27;346:f1323. doi: 10.1136/bmj.f1323.
10
Trauma experts urge cautious use of i.v. fluids.
Am J Health Syst Pharm. 2012 Nov 1;69(21):1846, 1848. doi: 10.2146/news120073.
引用本文的文献
1
Mitigation of supply chain challenges in cell therapy manufacturing: perspectives from the cord blood alliance.
Stem Cells Transl Med. 2024 Sep 10;13(9):843-847. doi: 10.1093/stcltm/szae048.
2
Human red blood cell behaviour in hydroxyethyl starch: probed by single cell spectroscopy.
RSC Adv. 2020 Aug 26;10(52):31453-31462. doi: 10.1039/d0ra05842d. eCollection 2020 Aug 21.
3
Perioperative colloid choice and bleeding in patients undergoing musculoskeletal surgery: An observational administrative database study.
Int J Crit Illn Inj Sci. 2021 Oct-Dec;11(4):223-228. doi: 10.4103/IJCIIS.IJCIIS_178_20. Epub 2021 Dec 18.
4
Analysis of Risk Factors for Perioperative Acute Kidney Injury and Management Strategies.
Front Med (Lausanne). 2021 Dec 24;8:751793. doi: 10.3389/fmed.2021.751793. eCollection 2021.
5
C-reactive Protein/Albumin Ratio and Acute Kidney Injury after Radical Cystectomy among Elderly Patients: A Propensity Score-Matched Analysis.
Dis Markers. 2020 Oct 27;2020:8818445. doi: 10.1155/2020/8818445. eCollection 2020.
6
Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature.
Hepat Med. 2020 Oct 27;12:153-172. doi: 10.2147/HMER.S264231. eCollection 2020.
7
Contemporary resuscitation of hemorrhagic shock: What will the future hold?
Am J Surg. 2020 Sep;220(3):580-588. doi: 10.1016/j.amjsurg.2020.05.008. Epub 2020 May 11.
8
Fresh frozen plasma attenuates lung injury in a novel model of prolonged hypotensive resuscitation.
J Trauma Acute Care Surg. 2020 Aug;89(2S Suppl 2):S118-S125. doi: 10.1097/TA.0000000000002719.
9
Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children.
Cochrane Database Syst Rev. 2019 Jul 19;7(7):CD012247. doi: 10.1002/14651858.CD012247.pub2.
10
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.
Cochrane Database Syst Rev. 2019 Jun 28;6(6):CD004039. doi: 10.1002/14651858.CD004039.pub2.
本文引用的文献
1
Mortality in patients with hypovolemic shock treated with colloids or crystalloids.
JAMA. 2014 Mar 12;311(10):1068-9. doi: 10.1001/jama.2014.836.
2
Reporting bias in trials of volume resuscitation with hydroxyethyl starch.
Wien Klin Wochenschr. 2014 Apr;126(7-8):189-94. doi: 10.1007/s00508-014-0503-y. Epub 2014 Mar 5.
3
Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
Br J Anaesth. 2014 Mar;112(3):595-600. doi: 10.1093/bja/aeu025.
4
Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial.
JAMA. 2013 Nov 6;310(17):1809-17. doi: 10.1001/jama.2013.280502.
5
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD007594. doi: 10.1002/14651858.CD007594.pub3.
6
Safety of modern starches used during surgery: misleading conclusions.
Anesth Analg. 2013 Aug;117(2):527-8. doi: 10.1213/ANE.0b013e318296913f.
7
Boldt: the great pretender.
BMJ. 2013 Mar 19;346:f1738. doi: 10.1136/bmj.f1738.
8
Colloids versus crystalloids for fluid resuscitation in critically ill patients.
Cochrane Database Syst Rev. 2013 Feb 28(2):CD000567. doi: 10.1002/14651858.CD000567.pub6.
9
Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.
JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430.
10
Hydroxyethyl starch or saline for fluid resuscitation in intensive care.
N Engl J Med. 2012 Nov 15;367(20):1901-11. doi: 10.1056/NEJMoa1209759. Epub 2012 Oct 17.
Zotero 插件